PubRank

T Bernatik

Author PubWeight™ 24.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008 1.48
2 An abdominal and thyroid status with Acoustic Radiation Force Impulse Elastometry--a feasibility study: Acoustic Radiation Force Impulse Elastometry of human organs. Eur J Radiol 2010 1.37
3 Measurement of liver elasticity with acoustic radiation force impulse (ARFI) technology: an alternative noninvasive method for staging liver fibrosis in viral hepatitis. Ultraschall Med 2010 1.30
4 Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001 1.26
5 Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Ultraschall Med 2010 1.11
6 Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos. Ultraschall Med 2009 1.10
7 Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Ultraschall Med 2009 1.03
8 Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol 2001 0.96
9 Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry. Ultraschall Med 2010 0.92
10 [Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol 2013 0.91
11 Cellular and vascular reactions in the liver to radio-frequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs. Eur Surg Res 2002 0.89
12 Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study. J Vasc Interv Radiol 2003 0.88
13 Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies. Ultraschall Med 2011 0.84
14 Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med 2011 0.83
15 Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome? Ultraschall Med 2012 0.83
16 [Renal cell cancer does not show a typical perfusion pattern in contrast-enhanced ultrasound]. Ultraschall Med 2009 0.82
17 Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall Med 2011 0.80
18 [Spectrum and bleeding complications of sonographically guided interventions of the liver and pancreas]. Ultraschall Med 2009 0.79
19 Hemodynamic efficacy of the new resolution clip device in comparison with high-volume injection therapy in spurting bleeding: a prospective experimental trial using the compactEASIE simulator. Endoscopy 2006 0.78
20 [Radio-frequency-ablation (RFA) with wet electrodes in the treatment of primary and secondary liver tumours]. Ultraschall Med 2003 0.78
21 Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience. Ultraschall Med 2007 0.77
22 Hepatic transit time: indicator of the therapeutic response to radiofrequency ablation of liver tumours. Br J Radiol 2005 0.77
23 Fluorescein-aided endomicroscopy for detection of signet ring cell carcinoma. Endoscopy 2011 0.77
24 Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation. Ultraschall Med 2005 0.77
25 Radiofrequency ablation using perfused needle electrodes - study of intermittent and continuous triple needle application ex vivo. Eur Surg Res 2005 0.76
26 [Prolonged survival through combined treatment with radiofrequency ablation/ethanol instillation compared with radiofrequency ablation alone in the VX2 rabbit liver tumour model]. Ultraschall Med 2007 0.76
27 [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls]. Ultraschall Med 2010 0.76
28 Radiofrequency ablation of liver tumors: how to enlarge the necrotic zones? Eur Surg Res 2004 0.75
29 Hepatic transit time in benign liver lesions. Ultraschall Med 2008 0.75
30 Mesenteric transit time using contrast-enhanced ultrasound (CEUS) does not correlate with disease activity in Crohn's disease. Ultraschall Med 2011 0.75